S. Folkertsma

The nuclear receptor ligand-binding domain: from biological function to drug design. A protein family-based approach

S. Folkertsma, 2006 .

Structure–activity relationship studies of miniproteins targeting the androgen receptor–coactivator interaction

L. Brunsveld, L. Milroy, S. Möcklinghoff, 2013 .

Computational design, synthesis, and evaluation of miniproteins as androgen receptor coactivator mimics.

L. Brunsveld, J. de Vlieg, S. Möcklinghoff, 2009, Chemical communications.

The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain.

G. Vriend, J. de Vlieg, P. V. van Noort, 2007, Molecular endocrinology.

A family-based approach reveals the function of residues in the nuclear receptor ligand-binding domain.

Emmanuel Bettler, Henk-Jan Joosten, Simon Folkertsma, 2004, Journal of molecular biology.

TAK1 activation of the mouse JunB promoter is mediated through a CCAAT box and NF‐Y

L. Jonk, B. Eggen, W. Kruijer, 2001, FEBS letters.

NRMD: Nuclear Receptor Mutation Database

Joost J. J. van Durme, Gert Vriend, Emmanuel Bettler, 2003, Nucleic Acids Res..

The nuclear receptor ligand-binding domain: a family-based structure analysis.

G. Vriend, J. de Vlieg, P. V. van Noort, 2005, Current medicinal chemistry.